Experts at the 10th World Ayurveda Congress in Dehradun criticized Western restrictions on Ashwagandha, citing financial and political motivations. They emphasized the herb's long history of safe medicinal use in India, contrasting it with Western companies using leaf extracts for supplements. Panelists also urged further clinical trials and improved documentation to strengthen Ayurveda's evidence base for wider acceptance.
